Israeli cannabis producer InterCure’s proposed acquisition of rival medical marijuana company Cann Pharmaceutical, also known as Better, was terminated after the companies failed to bridge differences. Read More
Subversive Real Estate Acquisition REIT is combining with Israeli marijuana producer InterCure in a deal that values InterCure at $300 million and is intended to secure a Nasdaq listing for the combined company.
Israel announced a road map to legalize cannabis potentially within one year and, in doing so, would create a regulated market for adult-use marijuana products largely based on Canada’s legalization model.
The number of authorized medical cannabis patients in Israel has more than doubled in the past two years – topping 70,000 – despite persistent supply and regulatory challenges, according to new data from the Israeli Medical Cannabis Agency (IMCA).